Chain of Compliance® is vital for the Regenerative Medicine Advanced Therapy (RMAT) market which presents a major opportunity for the industry. In a recent Contract Pharma article, Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, discusses why the Chain of Compliance® is critical to winning in the RMAT market. Read more >
Questions or comments? We welcome your feedback!
Email Us
